Articles tagged with "DMARD"

FDA Responds to New Drug Application for Baricitinib

June 15, 2017 • By Michele B. Kaufman, PharmD, BCGP

The OPAL Beyond Study: Tofacitinib Phase 3 Results Positive for Treating PsA

December 20, 2016 • By Michele B. Kaufman, PharmD, BCGP

Myocardial Inflammation Elevated in Active RA, Eases with DMARD Therapy

November 18, 2016 • By Megan Brooks

Rheumatology Drug Updates: Infliximab Biosimilar Cross Reacts to Infliximab Antibodies

August 11, 2016 • By Michele B. Kaufman, PharmD, BCGP

3 Clinical Trials Examine Sirukumab for RA; Plus TNF-α Combination & Monotherapies Are Compared for Treating PsA

January 27, 2016 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates on Brentuximab Vedotin, Tofacitinib Citrate

November 17, 2015 • By Michele B. Kaufman, PharmD, BCGP

High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence

May 29, 2015 • By Richard Quinn

Socioeconomic Factors Contribute to Inconsistent Use of DMARDs Among Patients with RA

September 12, 2014 • By Richard Quinn

Why Do We Wait to Help Patients?

June 13, 2011 • By Heather Haley, MS

Cobra Therapy for Rheumatoid Arthritis

June 1, 2010 • By Lilian H.D. van Tuyl, PhD, and Maarten Boers, MD, PhD